ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies (2021)

First Author: Fielding C
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.06.438630

Publication URI: http://dx.doi.org/10.1101/2021.04.06.438630

Type: Preprint